Sally Stephens Email & Phone Number

San Francisco Bay Area

• Manages consulting practice that develops innovative strategies to win in the changing healthcare environment and implementing those strategies through partnerships, collaborations and licensing
• Created and implemented strategy for Fortune 100 IT company to increase brand awareness in healthcare sector, drive economic benefit, and leverage current educational infrastructure
• Developing strategy for Permanente physicians (part of Kaiser Permanente) to have a voice in the delivery system reform debate at both the national and state levels
• Consulted with small diagnostic companies to forge and negotiate new relationships
• Consulting with small pharma company to renegotiate current agreement to improve economic terms

• Led business development activities for diagnostics business unit (annual revenue of more than $800M), including licensing, collaboration and acquisition negotiations. Oversaw activities of Project Management Office..
• Led several cross-functional strategy teams to identify technologies, markets and potential acquisition targets for entry into the molecular diagnostics market, specific emphasis on infectious disease and oncology..
• Led negotiations team and executed agreement for a worldwide exclusive license of a cancer biomarker, which represented the first major milestone in the execution of the molecular diagnostics strategy. Agreement.
• Chief liaison and negotiator with a large partner, Ortho Clinical Diagnostics

• Played a leading role in supporting the worldwide blood testing business, leading business development and strategy activities. Conducted due diligences on business opportunities, merger and acquisition candidates.
• Led several cross-function strategy teams to identify technologies, markets and potential acquisition targets to expand Chiron’s blood banking business
• Led negotiations team and executed agreement for a collaboration with a small biotech company specializing in creating universal blood that expanded Chiron’s business beyond testing. Quickly assessed potential.
• Led negotiations and executed acquisition of a small biotech company allowing Chiron to solidify its position in the prion field (key strategic imperative and large potential market)
• Led strategic marketing activities, including a world-wide market expansion strategy to prioritize target markets, obtaining buy-in of process and results from senior leaders; and a cost effectiveness analysis for the.

• Director of Performance Improvement (The Permanente Federation)National consultant for key performance improvement goals of the Permanente Medical Groups (PMGs), with total of 10,000 physicians.
• Assessed PMG performance and developed action plans for needed improvements, with particular focus on HEDIS scores and member/patient satisfaction
• Acted as liaison with the Pharmacy groups throughout the country, including development of a health economics-based protocol for the use of COX-2 inhibitors Director of Medical Group Affairs (The Permanente Federation).
• Assisted in development of Kaiser Permanente national strategy and principles guiding the financial relationships between the PMGs and the local Health Plans
• As the second employee of the Federation, played the role of CFO, head of Human Resources and Medical Group liaison for the first 6-9 months. Used communication, planning and management skills to build functioning.
• Assisted in development and creation of The Permanente Federation, focusing on legal, financial and operational issues

Conducted costing and pricing analyses for new products and services. Conducted study determining optimal service configurations. Participated in negotiations with key customers.

Performed market assessment, competitive analysis, acquisition analysis and strategic formulation in the pharmaceutical, medical device and diagnostic markets.

Mba, Healthcare And Finance

Bs, Chemical Engineering

Interdisciplinary Option in Applied Biology

Education record